Clinical observation on 64 cases of pediatric bronchopneumonia with phlegm heat obstructing the lung pattern treated with Pingchuan Zhike Heji(平喘止咳合剂)as an adjuvant therapy
Objective To observe the clinical efficacy of Pingchuan Zhike Heji(平喘止咳合剂)as an adju-vant therapy in the treatment of pediatric bronchopneumonia with phlegm heat obstructing the lung pattern.Methods A total of 128 pediatric patients with bronchopneumonia of phlegm heat obstructing the lung pattern who were treated in the Department of Pediatrics,Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University from September 2021 to September 2022 were selected and randomly divided into a treatment group and a control group,with 64 patients in each group.The control group received conventional Western medical treatment,while the treatment group was given Pingchuan Zhike Heji orally in addition to the treatment in the control group.Both groups were treated for 7 days as one course of treatment,and the therapeutic effects were e-valuated after one course of treatment.Results The total effective rate in the treatment group was 95.31％(61/64),significantly higher than 84.38％(54/64)in the control group,with a statistically significant difference between the two groups(P＜0.05).The time for the disappearance of symptoms such as shortness of breath,cough and expectoration,fever,and lung rales was significantly shorter in the treatment group compared to the control group,with statistically significant differences between the two groups(P＜0.01).Before treatment,there were no significant differences in serum hypersensitive Creactive protein(hs-CRP)and procalcitonin(PCT)levels between the two groups(P＞0.05),indicating comparability.After treatment,the serum hs-CRP and PCT levels in both groups were significantly decreased compared to before treatment,with statistically significant differences(P＜0.05),and the decrease was more pronounced in the treatment group(P＜0.05 or P＜0.01).During the treat-ment,there was 1 case of vomiting in the control group and 1 case of skin allergy and rash in the treatment group,but none of these affected the treatment,and there was no statistically significant difference between the two groups(P＞0.05).Conclusion Pingchuan Zhike Heji as an adjuvant therapy for pediatric bronchopneumonia of phlegm heat obstructing the lung pattern can effectively alleviate clinical symptoms,promote the absorption of lung lesions,improve local inflammatory reactions,and has significant clinical efficacy,making it worthy of clinical promotion and application.
bronchopneumoniapediatricphlegm heat obstructing the lung patternPingchuan Zhike Heji(平喘止咳合剂)clinical observation
NETL
NSTL
万方数据
